Avaí Bio Logo
  • Home
  • Diabetes
  • Klotho
  • Cell Encapsulation
  • Investor Relations
  • Contact
Avaí Bio Logo
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
    • Management Team
    • Contacts
    • FAQ
  • Presentations
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • Board of Directors
Avaí Bio Logo
  • Home
  • Diabetes
  • Klotho
  • Cell Encapsulation
  • Investor Relations
  • Contact

Press Releases

 

Navigation
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
    • Management Team
    • Contacts
    • FAQ
  • Presentations
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • Board of Directors
  • Quick Links
  • Email Alerts
  • Contacts
  • RSS News Feed
  • All News
  • 2026
  • 2025
  • 2024
  • 2023
  • 2022

Game Changing AI Applications from Healthcare to Marketing to Gaming

Dec 18, 2024

Avai Bio and Ainnova Secure Advanced AI Algorithms for Early Detection of Four Additional Diseases in the U.S.

Dec 17, 2024

Avai Bio Partner, Ainnova, Signs Pilot Program With Roche to Combat Diabetic Retinopathy

Dec 04, 2024

Avai Bio and Ainnova Advancing Proprietary Retinal Camera to Market With Vision AI Software

Nov 20, 2024

Avai Bio and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence

Nov 12, 2024

The big winner if OpenAI becomes a for-profit business? Microsoft.

Oct 05, 2024

Avai Bio Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care

Sep 24, 2024

Avai Bio Announces Strategic Review Process Intended to Maximize Shareholder Value

Sep 04, 2024

Avai Bio Announces Strategic Review Process Intended to Maximize Shareholder Value

Sep 04, 2024

Avai Bio to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions

Aug 21, 2024

RSS
« First « Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next » Last »
Avai Bio

Contact Us

Call: 866.533.0065

Fax: 702.872.2060

info@avaibio.com

Company

Diabetes Klotho Cell Encapsulation Investor Relations

Copyright © 2026 Avaí Bio, Inc. All rights reserved.

Spyr
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.